- No public price.
- Attested
- Type II
- 5
- —
- US
Decision support
Octagos
by Octagos · US
Remote cardiac device monitoring where AI triages implantable device transmissions and US specialists review them, for cardiology clinics.
On this page
43/100
Editorial rating 3.0 / 5
- Regulatory & Compliance10/22
HIPAA + (SOC2 or BAA) attested
- Clinical Integration7.6/11.6
Epic + Oracle Cerner + Athena
- Evidence Strength14.7/30
2 peer-reviewed papers
- Vendor & Market3/18
Seed-stage or unfunded
- Sentiment & Transparency1.3/2.5
Pricing on request, no public amounts
▸ Show all 11 dimensions▾ Hide dimension detail
- FDA clearance0/12
No FDA clearance listed
- HIPAA / SOC2 / BAA10/10
HIPAA + (SOC2 or BAA) attested
- EHR integrations (count)3/6
5 EHR integrations
- Top-3 EHR coverage (Epic / Oracle / Athena)5/5
Epic + Oracle Cerner + Athena
- Bidirectional write-back0/1
No bidirectional write-back documented
- Peer-reviewed papers15/21
2 peer-reviewed papers
- RCT / meta-analysis / systematic review0/9
No RCT, meta-analysis, or systematic review
- Funding & adoption signal3/12
Seed-stage or unfunded
- Years in market0/6
Founded year not recorded
- Pricing transparency1/3
Pricing on request, no public amounts
Remote cardiac device monitoring where AI triages implantable device transmissions and US specialists review them, for cardiology clinics.
No public price. HIPAA + SOC 2 Type II attested. integrates with Epic, Oracle Health, athenahealth (and 2 more).
Evidence record
No FDA decision cited in our research as of November 2, 2026.
2 studies on PubMed: 2 other, published 2023 to 2025. Read the literature summary
- Score computed November 2, 2026, method 1.2.0
- Review written November 2, 2026
MedAI Verdict, Octagos record, https://medaiverdict.com/tools/octagos, version November 2, 2026
Bottom line
Octagos is a remote monitoring service for implanted cardiac devices. The vendor says its Atlas AI sorts incoming transmissions, an IBHRE-certified specialist reviews them, and a physician e-signature is required for every report. The pricing page runs from Pro, which is software only, to Premium, which adds clinical and patient engagement services, so a cardiology practice can buy the tool or the outsourced review. The vendor does not say whether Atlas AI is FDA-cleared, exempt or decision support, and a group that requires a cleared triage algorithm should look elsewhere.
How does a transmission become a signed report?
The vendor calls its method a "Two Brain Approach". Atlas AI filters out transmissions that need no action, ranks the urgent ones and drafts a structured report for technicians to review. The vendor says a patient engagement team works to keep patients transmitting.
Around that sit Ask Atlas, a natural-language query layer for care, billing and operations, and OctaLink, a mobile app for alert review and documentation. Analytics cover device volume by manufacturer, procedure candidates and recall search. AutoBiller and AutoNotes pair device events with CPT and ICD-10 codes.
Where does the 99.1% figure come from?
A 2025 JACC Advances paper, "Role of Artificial Intelligence in Reducing Data Deluge From Cardiac Implantable Electronic Devices" (PMID 40882604), is the Octagos-linked study behind the vendor's AI overview page. The vendor's reading of it is 690,673 transmissions from 74,217 devices at 78 US clinics, with Atlas AI at 99.1% sensitivity against 70.8% for technicians.
A reply letter in the same journal (PMID 40682892) is commentary. A third 2025 JACC Advances paper on AI-enhanced insertable cardiac monitors (PMID 40107046) carries an Octagos affiliation, and whether it concerns Atlas AI is not verified. The homepage adds a 300% average ROI increase per customer and 94% billing efficiency within 90 days in one case study, both unverified.
Is Atlas AI a regulated device?
The AI overview page does not say whether Atlas AI is FDA-cleared, FDA-exempt or classed as wellness or decision support, and the 510(k) records hold nothing under Octagos or Octagos Health.
Who runs it and what does it connect to?
Octagos lists a Houston, Texas address. Shanti Bansal, MD, a practicing cardiac electrophysiologist, is founder and CEO, and Ilyas Colombowala, MD, is chief medical officer. The legal entity, founding year, ownership and funding are not stated, and a "VivaLink" link in the navigation is unexplained. The vendor claims 300+ customers, more than 1 billion transmission pages processed, 21 days on average to EHR go-live, and a place on TIME's HealthTech lists for 2025 and 2026.
The vendor lists Epic via SMART on FHIR with single sign-on, plus Oracle Health, athenahealth, medent and NextGen, and gives its EHR integrations as "over 170" in one place and "200+" in another. It calls itself vendor-neutral on devices and names Abbott, Medtronic, Boston Scientific, BIOTRONIK and CardioMEMS. The homepage states HIPAA compliance and SOC 2 Type 2 and SOC 3 certification, on Microsoft Azure.
Octagos publishes no amounts. The pricing page names Pro, Premium (marked "Popular"), Flex for on-demand services and Custom, with billing by billable transmission, a fixed monthly fee or a custom plan.
The verdict
Premium is the tier for a practice that wants someone else to do first-pass review and patient follow-up, and Pro is the tier for one that has the technicians and wants the software. The sensitivity figure behind Atlas AI is the vendor's reading of an Octagos-linked study.
Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.
What it costs
All tiers are custom-quoted. The vendor does not publish per-provider list pricing.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | Not stated | Not stated | No public price. |
Source: vendor pricing page. Last checked November 2, 2026.
What deploys cleanly
Carries HIPAA, SOC 2 Type II, SOC 3 per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment. Integrates with 5 EHRs: Epic, Oracle Health, athenahealth, medent, NextGen.
What the literature says
2 peer-reviewed studies indexed on PubMed evaluate Octagos in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Impact of Artificial Intelligence-Enhanced Insertable Cardiac Monitors on Device Clinic Workflow and Resource Utilization. (opens in new tab)
- Katapadi A, Chelikam N, Rosemas S, et al.· JACC Adv· 2025
- Insertable cardiac monitors (ICMs) are essential for managing arrhythmias but often generate large numbers of transmissions and false alerts. Integrating artificial intelligence (AI) as part of the ICM workflow can reduce this burden. However, its impact on clinic workflow and resource utilization must be better understood. The aim of the study was to assess the impact of AI-enhanced ICMs on clinic workflow and resource utilization. A cross-sectional analysis was conducted using real-world, deidentified ICM remote monitoring data from Octagos Health, which included 140 U.S. device clinics bet…
- Data deluge from remote monitoring of cardiac implantable electronic devices and importance of clinical stratification. (opens in new tab)
- Bawa D, Kabra R, Ahmed A, et al.· Heart Rhythm O2· 2023
- Remote monitoring (RM) has been accepted as a standard of care for follow-up of patients with cardiac implantable electronic devices (CIEDs). However, the resulting data deluge poses major challenge to device clinics. This study aimed to quantify the data deluge from CIED and stratify these data based on clinical relevance. The study included patients from 67 device clinics across the United States being remotely monitored by Octagos Health. The CIEDs included implantable loop recorders, pacemakers, implantable cardioverter-defibrillators, cardiac resynchronization therapy defibrillators, and…
Other decision support
See the full decision support rankingUpToDate Expert AI
by Wolters Kluwer
Generative AI version of UpToDate that answers only from UpToDate's expert-authored library. Included in UpToDate subscriptions in the US.
July 2026 figure from a third-party price comparison; the vendor page shows no amount. Wolters Kluwer states Expert AI is included in all UpToDate subscriptions in the US. Trainees $219 per year with proof.
OpenEvidence
by OpenEvidence
Free physician-only literature-grounded Q&A, 1M consults/day.
Free for NPI-verified physicians (ad-funded).
Doximity Ask
by Doximity
Free clinical AI assistant for verified US clinicians, built on Pathway's technology.
Free for verified US clinicians, funded by advertising, per third-party summaries. Doximity's pages returned 403 when read. Also part of enterprise contracts with health systems.DynaMed / Dyna AI
by EBSCO Health
Evidence-based clinical reference from EBSCO with Dyna AI, a generative Q&A add-on, and Epic integration.
Individual plan from the EBSCO store.